CHS Inc.
NASDAQ:CHSCLAgricultural Farm Products
-$0.05 today
- Market cap
- $294.90M
- Beta
- 0.10
- P/E (TTM)
- 0.0
- EPS (TTM)
- $0.00
- Dividend yield
- 7.37%
Volume 0.12M
Average 0.02M
CHSCL Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
CHS Inc.NASDAQ: CHSCL
Accounts Receivables · Q2 FY2026 · quarter ended Feb 2026
Accounts receivables turns negative
Q2 FY2026 accounts receivables was -$12.98M, compared with $249.48M a year earlier. Trailing-twelve-month accounts receivables was -$367.61M.
Context
- Accounts receivables amounted to 0.0% of revenue in FY2025, down 0.8 pp from a year earlier.
- Accounts receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near -$12.98M or moves back toward the trailing-twelve-month quarterly average of -$91.9M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- 7M USD
- Year-over-year change
- +102.1%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | 7M | +102.1% |
| FY2024 | 2024-08-31 | (335.97M) | -152.0% |
| FY2023 | 2023-08-31 | 645.78M | +217.9% |
| FY2022 | 2022-08-31 | (547.56M) | +3.7% |
| FY2021 | 2021-08-31 | (568.75M) | — |
Accounts Receivables vs competitors
How CHSCL compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts receivables is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -373.6% is the lowest of 10, against a peer median of +156.6%.
- Accounts receivables amounts to 1.0% of revenue for CHSCL, versus a peer median of 2.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Feb 2026 | $367.61M USD | -373.6% | — | 1.0% | |
| LTM Mar 2026 | R$26.82M BRL | +132.2% | +11.8% | 4.9% | |
| LTM Mar 2026 | ₪18.2M ILS | +53.8% | — | 2.9% | |
| LTM Apr 2026 | $14.35M USD | +346.9% | — | 0.8% | |
| LTM Mar 2026 | $9.37M USD | +346.5% | -53.1% | 2.2% | |
| LTM Mar 2026 | $8.22M USD | +596.0% | -44.1% | 50.1% | |
AFRIForafric Global PLC | LTM Jun 2024 | $6.41M USD | — | — | 2.0% |
| LTM Apr 2026 | $5.85M USD | -20.2% | -36.8% | 4.4% | |
SLSNSolesence, Inc. Common Stock | LTM Mar 2026 | $2.71M USD | +171.2% | +35.1% | 4.5% |
| LTM Mar 2026 | $2.31M USD | +30.3% | — | 0.5% | |
| LTM Mar 2026 | $950.1K USD | +156.6% | — | 0.4% | |
| Peer median (excluding CHSCL) | — | +156.6% | -36.8% | 2.6% | |
Competitors are the stored peer set for CHSCL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Net Income | 553.95M | 1.68B | 1.9B | 1.1B | 598M |
| Depreciation & Amortization | 461.73M | 461.97M | 464.62M | 481.72M | 651.43M |
| Deferred Income Tax | (11.96M) | 39.55M | (6.43M) | (109.85M) | (38.74M) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | (190.45M) | (247.58M) | 992.11M | (324.36M) | (464.4M) |
| Accounts Receivables | (568.75M) | (547.56M) | 645.78M | (335.97M) | 7M |
| Inventory | (549.22M) | (317.92M) | 437.69M | 147.76M | (53.18M) |
| Accounts Payables | 1.01B | 555.45M | (127.4M) | (213.79M) | (276.11M) |
| Other Working Capital | (79.7M) | 62.46M | 36.03M | 77.64M | (142.1M) |
| Other Non-Cash Items | (55.47M) | 13.82M | (66.55M) | 123.04M | (110.49M) |
| Operating Cash Flow | 757.81M | 1.95B | 3.28B | 1.27B | 635.79M |
| Capital Expenditures | (358.72M) | (379.21M) | (781.94M) | (831.51M) | (999.96M) |
| Acquisitions (Net) | 102.11M | 87.47M | 29.71M | 15.82M | (237.17M) |
| Purchases of Investments | 0 | 0 | 0 | (500.18M) | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 513.31M |
| Other Investing Activities | 154.94M | (165.34M) | (197.97M) | (947.23M) | (1.16B) |
| Investing Cash Flow | (101.67M) | (457.08M) | (950.19M) | (1.43B) | (880.6M) |
| Debt Repayment | (41.84M) | (785.17M) | (202.42M) | 74.22M | 525.54M |
| Common Stock Issued | 79.38M | 111.82M | 0 | 0 | 0 |
| Common Stock Repurchased | (79.38M) | (111.82M) | (495.79M) | (355.93M) | (287.68M) |
| Dividends Paid | (168.67M) | (168.67M) | (168.67M) | (168.67M) | (469.03M) |
| Other Financing Activities | (36.7M) | (48.03M) | (528.59M) | (363.88M) | 600K |
| Financing Cash Flow | (326.59M) | (1.11B) | (1.4B) | (814.25M) | (230.57M) |
| Effect of Forex Changes | (4.06M) | (14.76M) | 2.59M | 2.24M | 773K |
| Net Change in Cash | 325.49M | 360.99M | 941.11M | (970.73M) | (474.6M) |
| Free Cash Flow | 399.1M | 1.57B | 2.5B | 441.37M | (364.17M) |
CHS Inc.
NASDAQ:CHSCL
Intrinsic Alpha fair value
Locked
Current Price
$24.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.